載入...

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, co-treatment with bevacizumab and cytotoxic chemotherapy showed less toxicity and a significant disease control rate, we aimed to evaluate the...

全面介紹

Na minha lista:
書目詳細資料
發表在:Sci Rep
Main Authors: Bang, Yeong Hak, Kim, Jeong Eun, Lee, Ji Sung, Kim, Sun Young, Kim, Kyu-Pyo, Kim, Tae Won, Hong, Yong Sang
格式: Artigo
語言:Inglês
出版: Nature Publishing Group UK 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007566/
https://ncbi.nlm.nih.gov/pubmed/33782470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86482-x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!